Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
6239 Results Found
CDC: U.S. measles cases at 884; MMR vaccine ‘essential’ to prevent outbreaks
There have been 884 confirmed cases of measles nationwide so far this year, with cases reported by 29 states, according to the latest data from the Centers for Disease Control and Prevention.
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride Injection 500mg/100mL Infusion bags due to the products potentially containing inert polypropylene fibers.
Voice of the President | May 2025
As we embrace the opportunities and confront the challenges we face this year, AONL stands committed to promoting and enhancing expert nursing leadership.
AHRMM25 Conference & Exhibition
Join us at AHRMM25 Conference & Exhibition, August 3-6 in Denver, Colorado for the leading event for health care supply chain.
Hospitals Are Cornerstones of Communities. We Must Tell Our Stories to Protect Access to Care
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget.
Recall issued for aspiration system by Q’Apel Medical
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel rupture and a vasospasm.
CDC may move to risk-based COVID-19 vaccine strategy
A majority of the COVID-19 vaccine work group members at the Centers for Disease Control and Prevention support ending the agency’s recommendation for nearly all Americans to get vaccinated each year against the virus.
Cassidy releases report calling for reforms to 340B program
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., April 24 released a report detailing findings from an investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program.